Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals
ROCKVILLE, Md., April 1 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) announced today that it has completed the previously announced sale of 12.5 million shares of Novavax's common stock at $0.88 per share to a wholly owned subsidiary of Cadila
Pharmaceuticals as part of the new stra...
Zydus Cadila and Kopran in strategic alliance
The Ahmedabad-based Zydus Cadila
Healthcare announced a strategic alliance with Mumbai-based Kopran for marketing and manufacturing of formulation brands and collaborative research while taking over the Kopran's anti-hypertensive drug 'Aten' for Rs. 75 crores. Aten (Atenolol), is the largest brand ...
BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company
On April 1, 2009, Novavax Inc. raised approximately $10 million in net proceeds from the sale of common stock to a subsidiary of cadila
Pharmaceuticals as part of a new strategic alliance.
On July 20, 2009, OncoGenex Pharmaceuticals, Inc. raised approximately $9 million in net...
New Report Just Published: World Multiple Myeloma Therapeutics Market Report
MNKD and LLS Conclude Joint Research Agreement II-45
MorphoSys and DSM Enter into Agreement II-46
StemCyte Enters into Joint Venture with cadila
and Apollo Hospitals
in India II-46
ImmunoCellular Acquires Molecular Antibody Technology II-46
US House of Representatives Sanction the H...
Novavax Reports Fourth Quarter and 2008 Year-End Financial Results
...ch 31, Novavax announced a strategic alliance with cadila
Pharmaceutical Limited ("Cadila") of India. This ... $11.0 million by a wholly-owned subsidiary of cadila
12.5 million shares of No...
2. Formation of a joint venture between cadila
and Novavax in
India, which will be o...
One Pill Might Prevent Heart Disease
...vascular disease -- high blood pressure, high blood cholesterol and formation of artery-blocking blood clots. It is being tested by an Indian company, cadila
The idea was originated by a group of physicians trained in India and now at McMaster University in Canada, said Dr. Koon Teo, a professor ...
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
...maceuticals (USA) Inc., located in Princeton, N.J., is the U.S. division of cadila
Healthcare is India's 4th largest pharmaceutical company and has a presence...
Rutgers research partner Stemcyte, Inc., expands to New Jersey
...on therapies derived from umbilical cord blood.
StemCyte, which also has announced the development of a facility in India in collaboration with cadila
Pharmaceuticals and Apollo Hospitals, has operations in California and Taiwan. These facilities collect, process and store UCB stem cells to be used a...
India Finds New Use for an Old Bug
...amme should not face problems in India from regulatory angle because it is an already approved vaccine for leprosy and is commercially manufactured by cadila
Pharmaceuticals in Ahmedabad.
Talwar's group at AIIMS found the Mw organism among the collections in a tuberculosis hospital in Madras, now Chen...
List of 886 Drug Prices that has been Reduced by Govt. of India
...he names of 886 drugs in India where the price has been reduced by 0.026% to 74.53%. //These drugs belong to 11 pharmaceuticals include 391 drugs from cadila
The National Pharmaceutical Pricing Authority (NPPA) has been entrusted with the job of monitoring the prices of medicines. As per ...
Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
Joint Venture to be funded by Cadila
Pharmaceuticals and Revenues from Sales of Biogenerics; Deal Includes $11 Million Capital Investment in Novavax
ROCKVILLE, Md., March 31 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX ) announced today it has formed a joint venture with Cadila
"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila
TOKYO, July 30 /PRNewswire/ -- With a business plan to launch 8-10 new
products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of
the Zydus group, one of India's leading integrated pharma companies & a
global healthcare provider, is looking to give a big boost to its ope...
Novavax Reports Second Quarter 2009 Financial Results
...nched CPL Biologicals Pvt. Ltd, the previously announced joint venture with cadila
Pharmaceuticals, to develop and manufacture vaccines, biological therapeuti...hich were partially offset by net proceeds from the sale of common stock to cadila
of $10.7 million and proceeds from the sale of stock under the ATM program ...
Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
...irstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) and cadila
Pharmaceuticals today announced the launch of thei...ndia using technology contributed from Novavax and cadila
Pharmaceuticals. In addition, CPL Biologicals wil... stated: "We are excited to see the agreement with cadila
announced in March come to fruition with the offic...
Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
...gnificant vaccine manufacturing experience. This is the first opportunity to export our technology to Europe, following the recent joint venture with cadila
Pharmaceuticals in India, and is further validation of our unique in-border vaccine supply offering. This influenza vaccine supply solution consistin...
Novavax Reports First Quarter 2009 Financial Results
...convertible debt, and completed a transaction with cadila
Pharmaceutical Limited to create a Joint Venture C...es of common stock to a wholly owned subsidiary of cadila
Pharmaceuticals and raising approximately $7.5 mil...mmencement of operations of the joint venture with cadila
Pharmaceuticals Ltd in India; and,